BMY - Bristol Myers Cellares ink $380M CAR-T therapies supply deal April, 22 2024 09:51 AM Bristol-Myers Squibb Company 2024-04-22 09:51:41 ET Bristol Myers Squibb ( NYSE: BMY ) on Monday announced a $380M deal with contract manufacturer Cellares to produce CAR T cell therapies.... For further details see: Bristol Myers, Cellares ink $380M CAR-T therapies supply deal